Nordea Investment Management
VIR icon

Nordea Investment Management’s Vir Biotechnology VIR Stock Holding History

Nordea Investment Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.1M Buy
593,776
+13,021
+2% +$124K 0.01% 565
2026
Q1 		$5.09M Sell
580,755
-28,971
-5% -$231K ﹤0.01% 581
2025
Q4 		$3.55M Sell
609,726
-104,835
-15% -$624K ﹤0.01% 659
2025
Q3 		$3.93M Buy
714,561
+10,184
+1% +$52.1K ﹤0.01% 639
2025
Q2 		$3.68M Buy
704,377
+564,537
+404% +$3.03M ﹤0.01% 619
2025
Q1 		$891K Buy
139,840
+3,353
+2% +$29.8K ﹤0.01% 823
2024
Q4 		$1M Sell
136,487
-286,600
-68% -$2.26M ﹤0.01% 806
2024
Q3 		$3.24M Buy
423,087
+147,552
+54% +$1.28M ﹤0.01% 603
2024
Q2 		$2.43M Buy
275,535
+39,871
+17% +$382K ﹤0.01% 664
2024
Q1 		$2.41M Buy
235,664
+87,190
+59% +$888K ﹤0.01% 683
2023
Q4 		$1.5M Sell
148,474
-2,687
-2% -$24.6K ﹤0.01% 747
2023
Q3 		$1.42M Sell
151,161
-1,516
-1% -$21.6K ﹤0.01% 751
2023
Q2 		$3.78M Buy
152,677
+3,415
+2% +$85.8K 0.01% 575
2023
Q1 		$3.45M Sell
149,262
-4,833
-3% -$124K 0.01% 595
2022
Q4 		$3.84M Buy
154,095
+635
+0.4% +$15.6K 0.01% 570
2022
Q3 		$2.98M Sell
153,460
-558
-0.4% -$14.2K ﹤0.01% 620
2022
Q2 		$3.91M Buy
154,018
+2,483
+2% +$58K 0.01% 587
2022
Q1 		$3.99M Buy
151,535
+2,510
+2% +$74.4K 0.01% 621
2021
Q4 		$6.21M Buy
149,025
+139,722
+1,502% +$5.47M 0.01% 541
2021
Q3 		$414K Buy
+9,303
New +$403K ﹤0.01% 943

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nordea Investment Management's VIR Position: Q2 2026 in Review

Nordea Investment Management increased its Vir Biotechnology (VIR) stake by 2.2% in Q2 2026, buying an estimated $124K and bringing the position to 593,776 shares worth $6.1M. The position accounts for 0.01% of the portfolio, ranked #565.

Nordea Investment Management first reported a position in VIR in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.21M in Q4 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Nordea Investment Management held 593,776 shares of Vir Biotechnology worth $6.1M as of Q2 2026.
  • Nordea Investment Management bought 13,021 Vir Biotechnology shares in Q2 2026, an estimated $124K.
  • Vir Biotechnology made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #565 holding.
  • Nordea Investment Management first reported a position in Vir Biotechnology in Q3 2021 and has held it in 20 quarters since.
  • Nordea Investment Management's Vir Biotechnology position peaked at $6.21M in Q4 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.